SE9704546D0 - Novel compounds - Google Patents

Novel compounds

Info

Publication number
SE9704546D0
SE9704546D0 SE9704546A SE9704546A SE9704546D0 SE 9704546 D0 SE9704546 D0 SE 9704546D0 SE 9704546 A SE9704546 A SE 9704546A SE 9704546 A SE9704546 A SE 9704546A SE 9704546 D0 SE9704546 D0 SE 9704546D0
Authority
SE
Sweden
Prior art keywords
novel compounds
pharmaceutical compositions
therapy
preparing
preparation
Prior art date
Application number
SE9704546A
Other languages
English (en)
Swedish (sv)
Inventor
Andrew Baxter
David Cheshire
Thomas Mcinally
Michael Mortimore
Original Assignee
Astra Pharma Prod
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Astra Pharma Prod filed Critical Astra Pharma Prod
Priority to SE9704546A priority Critical patent/SE9704546D0/xx
Publication of SE9704546D0 publication Critical patent/SE9704546D0/xx
Priority to HU0100731A priority patent/HUP0100731A3/hu
Priority to TR2000/01544T priority patent/TR200001544T2/xx
Priority to EEP200000321A priority patent/EE200000321A/xx
Priority to IL13636898A priority patent/IL136368A0/xx
Priority to EP98962753A priority patent/EP1037889A1/en
Priority to PL98340837A priority patent/PL340837A1/xx
Priority to JP2000524280A priority patent/JP2001525406A/ja
Priority to SK844-2000A priority patent/SK8442000A3/sk
Priority to CA002312357A priority patent/CA2312357A1/en
Priority to AU17915/99A priority patent/AU1791599A/en
Priority to CN98813490A priority patent/CN1284074A/zh
Priority to KR1020007006117A priority patent/KR20010032800A/ko
Priority to BR9813378-0A priority patent/BR9813378A/pt
Priority to PCT/SE1998/002190 priority patent/WO1999029686A1/en
Priority to NO20002787A priority patent/NO20002787L/no

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/06Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/02Immunomodulators
    • A61P37/06Immunosuppressants, e.g. drugs for graft rejection
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/14Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D413/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/06Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D417/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/06Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Transplantation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
SE9704546A 1997-12-05 1997-12-05 Novel compounds SE9704546D0 (sv)

Priority Applications (16)

Application Number Priority Date Filing Date Title
SE9704546A SE9704546D0 (sv) 1997-12-05 1997-12-05 Novel compounds
PCT/SE1998/002190 WO1999029686A1 (en) 1997-12-05 1998-12-01 Novel compounds
PL98340837A PL340837A1 (en) 1997-12-05 1998-12-01 Novel compounds
SK844-2000A SK8442000A3 (en) 1997-12-05 1998-12-01 Hetorocyclic compounds, method for the preparation thereof, pharmaceutical composition comprising the same and their use
EEP200000321A EE200000321A (et) 1997-12-05 1998-12-01 Uudsed ühendid
IL13636898A IL136368A0 (en) 1997-12-05 1998-12-01 Novel compounds
EP98962753A EP1037889A1 (en) 1997-12-05 1998-12-01 Novel compounds
HU0100731A HUP0100731A3 (en) 1997-12-05 1998-12-01 New oxazolidine-, thiazolidine-, pyrrolidine-and piperidin derivatives process for their preparation and pharmaceutical compositions containing them
JP2000524280A JP2001525406A (ja) 1997-12-05 1998-12-01 新規な化合物
TR2000/01544T TR200001544T2 (tr) 1997-12-05 1998-12-01 Yeni bileşikler.
CA002312357A CA2312357A1 (en) 1997-12-05 1998-12-01 Novel compounds
AU17915/99A AU1791599A (en) 1997-12-05 1998-12-01 Novel compounds
CN98813490A CN1284074A (zh) 1997-12-05 1998-12-01 新化合物
KR1020007006117A KR20010032800A (ko) 1997-12-05 1998-12-01 신규 화합물
BR9813378-0A BR9813378A (pt) 1997-12-05 1998-12-01 Composto, processo para preparar o mesmo, e uso do mesmo, composição farmacêutica, e processo para a preparação da mesma, e, processo de efetuar a imunossupressão
NO20002787A NO20002787L (no) 1997-12-05 2000-05-31 Nye forbindelser

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE9704546A SE9704546D0 (sv) 1997-12-05 1997-12-05 Novel compounds

Publications (1)

Publication Number Publication Date
SE9704546D0 true SE9704546D0 (sv) 1997-12-05

Family

ID=20409283

Family Applications (1)

Application Number Title Priority Date Filing Date
SE9704546A SE9704546D0 (sv) 1997-12-05 1997-12-05 Novel compounds

Country Status (16)

Country Link
EP (1) EP1037889A1 (no)
JP (1) JP2001525406A (no)
KR (1) KR20010032800A (no)
CN (1) CN1284074A (no)
AU (1) AU1791599A (no)
BR (1) BR9813378A (no)
CA (1) CA2312357A1 (no)
EE (1) EE200000321A (no)
HU (1) HUP0100731A3 (no)
IL (1) IL136368A0 (no)
NO (1) NO20002787L (no)
PL (1) PL340837A1 (no)
SE (1) SE9704546D0 (no)
SK (1) SK8442000A3 (no)
TR (1) TR200001544T2 (no)
WO (1) WO1999029686A1 (no)

Families Citing this family (34)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE9901875D0 (sv) * 1999-05-25 1999-05-25 Astra Pharma Prod Novel compounds
SE9904505D0 (sv) 1999-12-09 1999-12-09 Astra Pharma Prod Novel compounds
SE9904652D0 (sv) 1999-12-17 1999-12-17 Astra Pharma Prod Novel Compounds
TWI258462B (en) 1999-12-17 2006-07-21 Astrazeneca Ab Adamantane derivative compounds, process for preparing the same and pharmaceutical composition comprising the same
JP2002330787A (ja) * 2000-10-21 2002-11-19 Astrazeneca Ab 化学物質
PA8557501A1 (es) 2001-11-12 2003-06-30 Pfizer Prod Inc Benzamida, heteroarilamida y amidas inversas
WO2003042190A1 (en) 2001-11-12 2003-05-22 Pfizer Products Inc. N-alkyl-adamantyl derivatives as p2x7-receptor antagonists
PA8591801A1 (es) 2002-12-31 2004-07-26 Pfizer Prod Inc Inhibidores benzamidicos del receptor p2x7.
US7071223B1 (en) 2002-12-31 2006-07-04 Pfizer, Inc. Benzamide inhibitors of the P2X7 receptor
EP1626962B1 (en) 2003-05-12 2007-02-28 Pfizer Products Inc. Benzamide inhibitors of the p2x7 receptor
GB0324498D0 (en) 2003-07-21 2003-11-26 Aventis Pharma Inc Heterocyclic compounds as P2X7 ion channel blockers
MXPA06014022A (es) 2004-06-29 2007-02-08 Pfizer Prod Inc Prcedimientos para preparar inhibidores de p2x7.
MX2008011919A (es) 2006-03-16 2008-11-28 Renovis Inc Compuestos de bicicloheteroarilo como moduladores de p2x7 y usos de los mismos.
TWI464148B (zh) 2006-03-16 2014-12-11 Evotec Us Inc 作為p2x7調節劑之雙環雜芳基化合物與其用途
ES2569677T3 (es) 2006-03-16 2016-05-12 Second Genome, Inc. Compuestos bicicloheteroarilo como moduladores de P2X7 y usos de los mismos
TW200813018A (en) 2006-06-09 2008-03-16 Astrazeneca Ab Novel compounds
GB0613473D0 (en) * 2006-07-06 2006-08-16 Glaxo Group Ltd Novel compounds
PL2049478T3 (pl) * 2006-07-06 2012-09-28 Glaxo Group Ltd Podstawione N-fenylometylo 5-okso-prolino-2-amidy jako antagoniści receptora P2X7 oraz sposoby ich zastosowania
EP2124562B1 (en) 2007-03-09 2016-04-20 Second Genome, Inc. Bicycloheteroaryl compounds as p2x7 modulators and uses thereof
WO2008116845A1 (en) * 2007-03-28 2008-10-02 Glaxo Group Limited Piperidinone carboxamide derivatives as p2x7 modulators
JP2010522710A (ja) * 2007-03-29 2010-07-08 グラクソ グループ リミテッド P2x7調節因子としてのオキサゾリジンおよびモルホリンカルボキサミド誘導体
KR20090127435A (ko) * 2007-04-03 2009-12-11 글락소 그룹 리미티드 P2x7 조절제로서의 이미다졸리딘 카르복스아미드 유도체
US8119661B2 (en) 2007-09-11 2012-02-21 Astrazeneca Ab Piperidine derivatives and their use as muscarinic receptor modulators
GB0803729D0 (en) * 2008-02-29 2008-04-09 Ge Healthcare Ltd Imaging the central nervous system
BRPI0910034B1 (pt) 2008-03-25 2022-02-08 Affectis Pharmaceuticals Ag Antagonistas do p2x7r e composições farmacêuticas que os compreendem
EP2243772B1 (en) 2009-04-14 2012-01-18 Affectis Pharmaceuticals AG Novel P2X7R antagonists and their use
EP2322149A1 (en) 2009-11-03 2011-05-18 Universidad del Pais Vasco Methods and compositions for the treatment of ischemia
AU2011252351A1 (en) 2010-05-14 2012-10-11 Affectis Pharmaceuticals Ag Novel methods for the preparation of P2X7R antagonists
WO2012110190A1 (en) 2011-02-17 2012-08-23 Affectis Pharmaceuticals Ag Novel p2x7r antagonists and their use
WO2012163456A1 (en) 2011-05-27 2012-12-06 Affectis Pharmaceuticals Ag Novel p2x7r antagonists and their use
WO2012163792A1 (en) 2011-05-27 2012-12-06 Affectis Pharmaceuticals Ag Novel p2x7r antagonists and their use
AU2018372136B2 (en) 2017-11-21 2022-01-27 Solventum Intellectual Properties Company Oral plant-based-oil-in-water emulsions and methods of use
EP3727336A1 (en) 2017-12-20 2020-10-28 3M Innovative Properties Company Oral compositions and methods of use
JP7308835B2 (ja) 2017-12-20 2023-07-14 スリーエム イノベイティブ プロパティズ カンパニー 口腔用組成物及び使用方法

Also Published As

Publication number Publication date
AU1791599A (en) 1999-06-28
SK8442000A3 (en) 2001-01-18
PL340837A1 (en) 2001-02-26
HUP0100731A3 (en) 2002-08-28
WO1999029686A1 (en) 1999-06-17
JP2001525406A (ja) 2001-12-11
EP1037889A1 (en) 2000-09-27
HUP0100731A2 (hu) 2002-05-29
IL136368A0 (en) 2001-06-14
KR20010032800A (ko) 2001-04-25
NO20002787D0 (no) 2000-05-31
NO20002787L (no) 2000-08-01
BR9813378A (pt) 2000-10-10
CN1284074A (zh) 2001-02-14
TR200001544T2 (tr) 2000-11-21
EE200000321A (et) 2001-08-15
CA2312357A1 (en) 1999-06-17

Similar Documents

Publication Publication Date Title
SE9704546D0 (sv) Novel compounds
EE200000320A (et) Uudsed ühendid
SE9704544D0 (sv) Novel compounds
MY125978A (en) Admantane derivatives
DE69905170D1 (en) Thiazolopyrimidinderivate
SE9901875D0 (sv) Novel compounds
AP9801392A0 (en) Concentrated antibody preparation.
EE200000318A (et) Uudsed ühendid
GR990100140A (el) Νεες ενωσεις
MX9602683A (es) Compuestos de 6-dimetilaminometil-1-fenil-ciclohexano como substancias farmaceuticamente activas.
SE9904505D0 (sv) Novel compounds
HUP0001508A3 (en) 4-arylmethylene-2-imino-2,3-dihydrothiazole derivatives, their use, process for the preparation thereof and pharmaceutical compositions containing them
SE9802937D0 (sv) Novel compounds
ZA9610460B (en) New phenylamidine derivatives, processes for preparing them and their use as pharmaceutical compositions.
EE03996B1 (et) Farmatseutilised kompositsioonid, nende valmistamismeetod ja kasutamine
IL134039A0 (en) Polyhydroxybutylpyrazines, their preparation and medicines containing them
ZA9811804B (en) 11ß-halogen-7Ó-substituted estratrienes, process for the production of pharmaceutical preparations that contain these 11ß-halogen-7Ó-substituted estratrienes as well as their use for the production of pharmaceutical agents.